http://www.medpagetoday.com
Larry Goldstein, M.D., director of the Duke Stroke Center in Durham, N.C.
NEW ORLEANS -- Thrombolytic therapy given three to six hours after symptom onset -- beyond the approved therapeutic window -- did not limit infarct growth in patients who theoretically might benefit from late reperfusion, investigators reported here.
Link to this comment:
All Comments (0)